It is hypothesized that under “normal” physiological conditions LCN2 is predominantly produced by bone, whereas in pathological states such as obesity and type 2 diabetes, production from adipose tissue is increased.7 Here, LCN2 is linked to obesity due to melanocortin 4 receptor deficiency.